Диссертация (1140384), страница 24
Текст из файла (страница 24)
Livchak, N. Gao, T. Palmer, G.K. Walkup, S.L.Fisher // The Journal of Biological Chemistry. – 2013. – Vol. 288, № 39. – P.27960–27971.77. Epp, S.F. C-terminal region of Pseudomonas aeruginosa outer membrane porinOprD modulates susceptibility to meropenem / S.F. Epp, T. Kohler, P. Plesiat, M.Michea-Hamzehpour,J.Frey,J.C.PechereAntimicrobialAgentsandChemotherapy. – 2001. – Vol. 45, № 6.
– P. 1780 – 1787.78. Eren, E. Substrate specificity within a family of outer membrane carboxylatechannels / E. Eren, J. Vijayaraghavan, J. Liu, B.R. Cheneke, D.S. Touw, B.W.154Lepore, M. Indic, L. Movileanu, B. van den Berg // PLoS Biology. – 2012. – Vol.10, № 1. – e1001242.79. European Committee on Antimicrobial Susceptibility Testing [электронныйресурс]//EUCASTExpertsrules,2016.–http://www.eucast.org/expert_rules_and_intrinsic_resistance/P.143(дата–URL:обращения:15.12.2017).80. European Committee on Antimicrobial Susceptibility Testing [электронныйресурс] // Breakpoint tables for interpretation of MICs and zone diameters.
– P. 11.– URL: http://www.eucast.org/clinical_breakpoints/ (дата обращения: 10.01.2018).81. Evans, J.C. Novel Insertion sequence, ISPa26, in oprD of Pseudomonas aeruginosais associated with carbapenem resistance / J.C. Evans, H.A. Segal // AntimicrobialAgents and Chemotherapy. – 2007. – Vol. 51. – № 10.
– P. 3776-3777.82. Fernandez, L. Adaptive resistance to the “last hope” antibiotics polymyxin B andcolistin in Pseudomonas aeruginosa is mediated by the novel two-componentregulatory system ParR-ParS / L. Fernandez, W.J. Gooderham, M.
Bains, J.B.McPhee, I. Wiegand, R.E. Hancock // Antimicrobial Agents and Chemotherapy. –2010. – № 54. – P. 3372–3382.83. Fernandez, L. Characterization of the Polymyxin B resistome of Pseudomonasaeruginosa / L. Fernandez, C. Alvarez-Ortega, I.
Wiegand, J. Olivares, D.Kocincova, J.S. Lam, J.L. Martinez, R.E.W. Hancock // Antimicrobial Agents andChemotherapy. – 2013. – Vol. 57, № 1. – P. 110–119.84. Fernando, D.M. Resistance-Nodulation-Division multidrug efflux pumps in gramnegative bacteria: role in virulence / D.M. Fernando, A. Kumar // Antibiotics. 2013.
– Vol. 2, №1. – P. 163–181.85. Fleiss, J.L. Statistical methods for rates and proportions / J.L. Fleiss, Levin B., PaikM.C. - New York: John Wiley & Sons, Inc.; 1981. - P.768.86. Foster, T. J. Plasmid-determined resistance to antimicrobial drugs and toxic metalions in bacteria / T.J. Foster // Microbiological reviews. – 1983.
– Vol. 47, № 3. – P.361–409.15587. Francisco, J.A. Transport and anchoring of beta-lactamase to the external surface ofEscherichia coli // J.A. Francisco, C.F. Earhart, G. Georgiou // Proceedings of theNational Academy of Sciences. – 1992. – Vol. 89, № 7. – P. 2713–2717.88. Galimand, M. Characterization of the aac(6′)-Ib gene encoding an aminoglycoside6′-N-acetyltransferase in Pseudomonas aeruginosa BM2656 / M. Galimand, T.Lambert, G. Gerbaud, P. Courvalin // Antimicrobial Agents and Chemotherapy.
–1993. – № 37. – P. 1456–1462.89. Garza-Ramos, U. Widespread of ESBL-and carbapenemase GES-type genes oncarbapenem-resistant Pseudomonas aeruginosa clinical isolates: a multicenter studyin Mexican hospitals / U. Garza-Ramos, H. Barrios, F. Reyna-Flores, E. TamayoLegorreta, J.C. Catalan-Najera, R. Morfin-Otero, J.
Gaytan-Martinez // Diagnosticmicrobiology and infectious disease. – 2015. – Vol. 81, № 2. – P. 135–137.90. Gazin, M. Current trends in culture-based and molecular detection of extendedspectrum-β-lactamase-harboring and carbapenem-resistant Enterobacteriaceae / M.Gazin, F. Paasch, H. Goossens, S. Malhotra-Kumar // Journal of ClinicalMicrobiology.
– 2012. – Vol. 50, № 4. – P. 1140–1146.91. Ghebremedhin, B. MALDI-TOF MS based carbapenemase detection from cultureisolates and from positive blood culture vials [Электронный ресурс] / B.Ghebremedhin, A. Halstenbach, M. Smiljanic, M. Kaase, P.
Ahmad-Nejad // Annalsof Clinical Microbiology and Antimicrobials. – 2016. – Vol. 15, № 5. – Режимдоступа: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736273.92. Ghosh, S. Chlorinated phenols control the expression of the multi-drug resistanceefflux pump MexAB-OprM in Pseudomonas aeruginosa by activating NalC / S.Ghosh, C.M. Cremers, U. Jakob, N.G. Love // Molecular microbiology. – 2011. –Vol.
79, № 6. – P. 1547–1556.93. Grobner, S. Emergence of carbapenem-non-susceptible extended-spectrum betalactamase-producing Klebsiella pneumoniae isolates at the university hospital ofTubingen, Germany / S. Grobner, D. Linke, W. Schütz, C. Fladerer, J. Madlung, I.B.156Autenrieth, W. Witte, Y.
Pfeifer // Journal of Medical Microbiology. – 2009. – Vol.58, № 7. – P. 912–922.94. Guillard, T. Rapid detection of aac(6′)-Ib-cr quinolone resistance gene bypyrosequencing / T. Guillard, V. Duval, H. Moret, L. Brasme, V. Vernet-Garnier, C.de Champs // Journal of Clinical Microbiology. – 2010. – Vol. 48, № 1.
– P. 286–289.95. Gurung, M. Emergence of 16S rRNA methylase gene armA and cocarriage ofblaIMP-1 in Pseudomonas aeruginosa isolates from South Korea / M. Gurung, D.C.Moon, M.D. Tamang, J. Kim, Y.C. Lee, S.Y. Seol, D.T. Cho, J.C. Lee // DiagnosticMicrobiology and Infectious Disease. – 2010. – № 68.
– P. 468–470.96. Gutu, A.D. Polymyxin resistance of Pseudomonas aeruginosa phoQ mutants isdependent on additional two-component regulatory systems / A.D. Gutu, N.Sgambati, P. Strasbourger, M.K. Brannon, M.A. Jacobs, E. Haugen, R.K. Kaul,H.K. Johansen, N. Hоiby, S.M. Moskowitz // Antimicrobial Agents andChemotherapy. – 2013. – Vol. 57, №5. – P.
2204–2215.97. Haas, M. Enzymatic modification of aminoglycoside antibiotics: a new 6′-Nacetylating enzyme from a Pseudomonas aeruginosa isolate / M. Haas, S.Biddlecome, J. Davies, C.E. Luce, P. Daniels // Antimicrobial Agents andChemotherapy. – 1976. – № 9. – P. 945–950.98. Hammoudi, D. How to detect carbapenemase producers? A literature review ofphenotypic and molecular methods / D. Hammoudi, C.A. Moubareck, D.K. Sarkis //Journal of Microbiological Methods. – 2014. – № 107.
– P. 106–118.99. Hancock, R.E.W. Resistance mechanisms in Pseudomonas aeruginosa and othernonfermentative gram-negative bacteria / R.E.W. Hancock // Clinical InfectiousDiseases. – 1998. – Vol. 27, №. 1. – P. S93–S99.100.Henrichfreise, B. Resistance mechanisms of multiresistant Pseudomonasaeruginosa strains from Germany and correlation with hypermutation / B.Henrichfreise, I.
Wiegand, W. Pfister, B. Wiedemann // Antimicrobial Agents andChemotherapy – 2007. – Vol. 51, № 11. – P. 4062–4070.157101.Hidron, A.I. Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National HealthcareSafety Network at the Centers for Disease Control and Prevention, 2006-2007 / A.I.Hidron, J.R.
Edwards, J. Patel, T.C. Horan, D.M. Sievert, D.A. Pollock, NationalHealthcare Safety Network Team // Infection Control Hospital Epidemiology. –2008. – № 29. – P. 996–1011.102.Hirabayashi, A. Risk factors for and role of OprD protein in increasing minimalinhibitory concentrations of carbapenems in clinical isolates of Pseudomonasaeruginosa / A. Hirabayashi, D. Kato, Y. Tomita, M. Iguchi, K. Yamada, Y.Kouyama, T. Yagi // Journal of Medical Microbiology. – 2017.
– Vol. 66, № 11. –P. 1562–157.103.Hocquet, D. Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa / D.Hocquet, A. Muller, K. Blanc, P. Plesiat, D. Talon, D.L. Monnet, X. Bertrand //Antimicrobial Agents and Chemotherapy. – 2008. – № 52. – P. 1173–1175.104.Hong, D.J. Epidemiology and characteristics of metallo-β-lactamase-producingPseudomonas aeruginosa // D.J.
Hong, I.K. Bae, I. Jang, S.H. Jeong, H. Kang, K.Lee // Infection and chemotherapy. – 2015. – Vol. 47, № 2. – P. 81-97.105.Hoyos-Mallecot, Y. MALDI-TOF MS, a useful instrument for differentiatingmetallo-β-lactamases in Enterobacteriaceae and Pseudomonas spp / Y. HoyosMallecot, J.J. Cabrera-Alvargonzalez, C. Miranda-Casas, M.D. Rojo-Martin, C.Liebana-Martos, J.M. Navarro-Mari // Letters in Applied Microbiology. – 2014. –Vol. 58, № 4. – P. 325–329.106.Hrabak, J. Carbapenemase activity detection by Matrix-Assisted LaserDesorption Ionization-Time of Flight Mass Spectrometry / J. Hrabak, R.
Walkova,V. Studentova, E. Chudackova, T. Bergerova // Journal of Clinical Microbiology. –2011. – Vol. 49, № 9. – P. 3222–3227.107.Hrabak, J. Matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) mass spectrometry for detection of antibiotic resistance mechanisms: from158research to routine diagnosis / J. Hrabak, E. Chudackova, R.Walkova // Clinicalmicrobiology reviews. – 2013. – Vol. 26, № 1.
– P. 103–114.108.Huang, H. Membrane topology and site-specific mutagenesis of Pseudomonasaeruginosa porin OprD / H. Huang, D. Jeanteur, F. Pattus, R.E. Hancock //Molecular Microbiology. – 1995. – Vol. 16, №5. – P. 931–941.109.Imperi, F. Analysis of the periplasmic proteome of Pseudomonas aeruginosa, ametabolically versatile opportunistic pathogen / F. Imperi, F. Ciccosanti, A.B.Perdomo, F. Tiburzi, C. Mancone, T. Alonzi, P. Ascenzi, M. Piacentini, P.















